Varicella vaccine (VARIVAX) in healthy children and adolescents : results from clinical trials, 1987 to 1989JO WHITE, C; KUTER, B. J; HILDEBRAND, C. S et al.Pediatrics (Evanston). 1991, Vol 87, Num 5, pp 604-610, issn 0031-4005Article

Antibody assays suitable for assessing immune responses to live varicella vaccinePROVOST, P. J; KRAH, D. L; KUTER, J et al.Vaccine. 1991, Vol 9, Num 2, pp 111-116, issn 0264-410X, 6 p.Article

Development of the formalin-inactivated hepatitis A vaccine, VAQTAARMSTRONG, M. E; GIESA, P. A; DAVIDE, J. P et al.Journal of hepatology. 1993, Vol 18, pp S20-S26, issn 0168-8278, SUP2Conference Paper

Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virusPROVOST, P. J; KELLER, P. M; BANKER, F. S et al.Journal of virology. 1987, Vol 61, Num 10, pp 2951-2955, issn 0022-538XArticle

Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulinLEMON, S. M; MURPHY, P. C; PROVOST, P. J et al.The Journal of infectious diseases. 1997, Vol 176, Num 1, pp 9-19, issn 0022-1899Article

Further evaluation of a live hepatitis A vaccine in marmosetsPROVOST, P. J; BANKER, F. S.K; WADSWORTH, C. W et al.Journal of medical virology. 1991, Vol 34, Num 4, pp 227-231, issn 0146-6615Article

Oka/Merck varicella vaccine in healthy children : final report fo a 2-year efficacy study and 7-year follow-up studiesKUTER, B. J; WEIBEL, R. E; GUESS, H. A et al.Vaccine. 1991, Vol 9, Num 9, pp 643-647, issn 0264-410XArticle

Enhancement of varicella-zoster virus plaquing efficiency with an agarose overlay mediumKRAH, D. L; SCHOFIELD, T. L; PROVOST, P. J et al.Journal of virological methods. 1990, Vol 27, Num 3, pp 319-326, issn 0166-0934Article

Viral enhancement and interference induced in cell culture by hepatitis A virus: application to quantitative assays for hepatitis A virusHURNI, W. M; MILLER, W. J; MCALEER, W. J et al.Proceedings of the Society for Experimental Biology and Medicine. 1984, Vol 175, Num 1, pp 84-87, issn 0037-9727Article

Modified cases of chickenpox after varicella vaccination : correlation of protection with antibody responseJO WHITE, C; KUTER, B. J; ELLIS, R. W et al.The Pediatric infectious disease journal. 1992, Vol 11, Num 1, pp 19-23, issn 0891-3668Article

The effects of freeze-drying on the potency and stability of live varicella virus vaccine. DiscussionBENNETT, P. S; MAIGETTER, R. Z; OLSON, M. G et al.Developments in biological standardization. 1992, Num 74, pp 215-221, issn 0301-5149Conference Paper

A simple antigen-reduction assay for the measurement of neutralizing antibodies to hepatitis A virusKRAH, D. L; AMIN, R. D; NALIN, D. R et al.The Journal of infectious diseases. 1991, Vol 163, Num 3, pp 634-637, issn 0022-1899Article

Establishment and characterization of a chronic infectious mononucleosislike syndrome in common marmosetsEMINI, E. A; LUKA, J; ARMSTRONG, M. E et al.Journal of medical virology. 1986, Vol 18, Num 4, pp 369-379, issn 0146-6615Article

Functional Definitions of Alcohol Abuse and Religious Entrepreneurs: A Research Note of Modern Aztec and American SocietiesNUSBAUMER, M. R; PROVOST, P. J.International Journal of Contemporary Sociology Ghaziabad. 1983, Vol 20, Num 3-4, pp 77-89Article

Combined use of complement and anti-immunglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virusKRAH, D. L; PROVOST, P. J; ELLIS, R. W et al.Journal of virological methods. 1995, Vol 53, Num 2-3, pp 176-187, issn 0166-0934Article

Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax®) in healthy adolescents and adultsKUTER, B. J; NGAI, A; PATTERSON, C. M et al.Vaccine. 1995, Vol 13, Num 11, pp 967-972, issn 0264-410XArticle

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations : an overviewNALIN, D. R; KUTER, B. J; WIENS, B et al.Journal of hepatology. 1993, Vol 18, pp S51-S55, issn 0168-8278, SUP2Conference Paper

Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis AELLERBECK, E. F; LEWIS, J. A; PROVOST, P. J et al.Vaccine. 1992, Vol 10, Num 10, pp 668-672, issn 0264-410XArticle

An inactivated hepatitis A viral vaccine of cell culture originPROVOST, P. J; HUGHES, J. V; MILLER, W. J et al.Journal of medical virology. 1986, Vol 19, Num 1, pp 23-31, issn 0146-6615Article

New findings in live, attenuated hepatitis A vaccine developmentPROVOST, P. J; BISHOP, R. P; GERETY, R. J et al.Journal of medical virology. 1986, Vol 20, Num 2, pp 165-175, issn 0146-6615Article

RégionsDROUIN, P; POUSSIER, J.-L; DOUDIÈS, A et al.Le Moniteur des travaux publics et du bâtiment. 1992, Num 4637, pp 145-165, issn 0026-9700Article

RégionsPOUSSIER, J.-L; THOMAS, T; TALPIN, J.-J et al.Le Moniteur des travaux publics et du bâtiment. 1992, Num 4634, pp 127-141, issn 0026-9700Article

RégionsANGLEZI, P; DONNAY, J; MANDRAUT, C et al.Le Moniteur des travaux publics et du bâtiment. 1992, Num 4636, pp 149-167, issn 0026-9700Article